Literature DB >> 23202778

The origin of stroma surrounding epithelial ovarian cancer cells.

Tomoko Akahane1, Akira Hirasawa, Hiroshi Tsuda, Fumio Kataoka, Sadako Nishimura, Hideo Tanaka, Eiichiro Tominaga, Hiroyuki Nomura, Tatsuyuki Chiyoda, Yoko Iguchi, Wataru Yamagami, Nobuyuki Susumu, Daisuke Aoki.   

Abstract

Cancer stroma is thought to play an important role in tumor behavior, including invasion or metastasis and response to therapy. Cancer stroma is generally thought either to be non-neoplastic cells, including tissue-marrow or bone-marrow-derived fibroblasts, or to originate in epithelial mesenchymal transition of cancer cells. In this study, we evaluated the status of the p53 gene in both the cancer cells and the cancer stroma in epithelial ovarian cancer (EOC) to elucidate the origin of the stroma. Samples from 16 EOC patients were included in this study. Tumor cells and adjacent nontumor stromal cells were microdissected and DNA was extracted separately. We analyzed p53 sequences (exons 5-8) of both cancer and stromal tissues in all cases. Furthermore, we examined p53 protein expression in all cases. Mutations in p53 were detected in 9 of the 16 EOCs: in 8 of these cases, the mutations were detected only in cancer cells. In 1 case, the same mutation (R248Q) was detected in both cancer and stromal tissues, and p53 protein expression was detected in both the cancer cells and the cancer stroma. Most cancer stroma in EOC is thought to originate from non-neoplastic cells, but some parts of the cancer stroma might originate from cancer cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23202778     DOI: 10.1097/PGP.0b013e3182518533

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

1.  NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.

Authors:  Kate Lawrenson; Barbara Grun; Nathan Lee; Paulette Mhawech-Fauceglia; Jenny Kan; Steve Swenson; Yvonne G Lin; Tanja Pejovic; Joshua Millstein; Simon A Gayther
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

Review 2.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kay-Pong Yip; Chi Lam Au Yeung; Stephen T C Wong; Samuel C Mok
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

3.  Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel.

Authors:  Shiwu Zhang; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Int J Cancer       Date:  2013-07-13       Impact factor: 7.396

Review 4.  Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts.

Authors:  Sergio Lamprecht; Ina Sigal-Batikoff; Shraga Shany; Naim Abu-Freha; Eduard Ling; George J Delinasios; Keren Moyal-Atias; John G Delinasios; Alexander Fich
Journal:  Cancers (Basel)       Date:  2018-02-27       Impact factor: 6.639

5.  Prolyl-4-Hydroxylase α Subunit 2 as a Novel Potential Biomarker for Predicting the Prognosis of Epithelial Ovarian Carcinoma.

Authors:  Haibo Zhang; Wei Zhao
Journal:  Cancer Manag Res       Date:  2021-06-03       Impact factor: 3.989

6.  Cytokines and Prognostic Factors in Epithelial Ovarian Cancer.

Authors:  Millena Prata Jammal; Agrimaldo Martins-Filho; Thales Parenti Silveira; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini
Journal:  Clin Med Insights Oncol       Date:  2016-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.